(HealthDay)—Olysio (simeprevir) has been approved by the U.S. Food and Drug Administration to treat chronic hepatitis C infection in adults.
The hepatitis C virus causes inflammation of the liver, which can inhibit the organ’s function and ultimately lead to deadly liver failure. Most…
Olysio approved as hepatitis C treatment
No comments:
Post a Comment